SCHEMBL4340978

SCHEMBL4340978

COc1cc2[nH]nc(-c3cc4ccccc4s3)c2cc1C(=O)NCc1ccco1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 9/20 0.46
MAPT P10636 5/20 0.46
TDP1 Q9NUW8 3/20 0.46
HPGD P15428 9/20 0.45
MEN1 O00255 6/20 0.45
KMT2A Q03164 6/20 0.45
KDM4E B2RXH2 5/20 0.45
HSD17B10 Q99714 4/20 0.45
SMN1; SMN2 Q16637 4/20 0.45
TSHR P16473 3/20 0.45
NPSR1 Q6W5P4 1/20 0.45
USP2 O75604 1/20 0.45
POLB P06746 3/20 0.45
CYP1A2 P05177 2/20 0.45
GLA P06280 2/20 0.45
CYP3A4 P08684 2/20 0.45
CYP2C9 P11712 2/20 0.45
CYP2C19 P33261 2/20 0.45
PKM P14618 1/20 0.45
RECQL P46063 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4334072 0.87 HPGD (0.47) ALDH1A1MAPTTDP1HPGDMEN1
SCHEMBL4335941 0.86 MAPT (0.49) ALDH1A1MAPTHPGDMEN1KMT2A
SCHEMBL4340622 0.85 KMT2A (0.52) ALDH1A1MAPTTDP1HPGDMEN1
SCHEMBL4332224 0.84 MAPT (0.46) ALDH1A1MAPTTDP1HPGDMEN1
SCHEMBL2864411 0.82 MAPK10 (0.46) MAPK1
SCHEMBL2862326 0.80 KDM4E (0.46) ALDH1A1HPGDKDM4EHSD17B10
SCHEMBL4329145 0.80 HPGD (0.48) ALDH1A1MAPTTDP1HPGDMEN1
SCHEMBL2870547 0.79 RAB9A (0.48) ALDH1A1SMN1; SMN2RAB9A
SCHEMBL4338881 0.79 KDM4E (0.53) ALDH1A1MAPTHPGDMEN1KMT2A
SCHEMBL4343390 0.79 HPGD (0.45) ALDH1A1MAPTTDP1HPGDMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7776890-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2010-08-17 US disclosed
US-7776890-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2010-08-17 US disclosed
US-20090203691-A1 Novel 1H-indazole compounds OINUMA HITOSHI 2009-08-13 US disclosed
US-20090203691-A1 Novel 1H-indazole compounds OINUMA HITOSHI 2009-08-13 US disclosed
US-7541376-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-06-02 US disclosed
US-20050282880-A1 Novel 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2005-12-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090203691-A1 Novel 1H-indazole compounds MAPK1, MAPK3, MAPK13 ALDH1A1 1588/4885MAPT 2644/4885TDP1 3905/4885
US-20050282880-A1 Novel 1H-indazole compounds MAPK1, MAPK3, MAPK13 ALDH1A1 1588/4885MAPT 2644/4885TDP1 3905/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.